SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-013730
Filing Date
2022-08-16
Accepted
2022-08-16 16:43:39
Documents
6
Period of Report
2022-09-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220929xdef14a.htm DEF 14A 692605
2 GRAPHIC tmb-20220929xdef14a009.jpg GRAPHIC 253517
3 GRAPHIC tmb-20220929xdef14a010.jpg GRAPHIC 218739
4 GRAPHIC tmb-20220929xdef14a003.jpg GRAPHIC 7501
5 GRAPHIC tmb-20220929xdef14a001.jpg GRAPHIC 5607
6 GRAPHIC tmb-20220929xdef14a002.jpg GRAPHIC 4854
  Complete submission text file 0001558370-22-013730.txt   1369751
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32587 | Film No.: 221170715
SIC: 2834 Pharmaceutical Preparations